AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
Want to see ANTX full AI Analyst Report?
An2-502998
Healthy Volunteers
Phase I
Recruiting
First-in-Human Trial of Oral AN2-502998
May 31, 2025
―
Epetraborole
Mac Lung Disease, Treatment Refractory Mac Lung Disease
Phase II/III
Terminated
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Mar 24, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AN2 Therapeutics, Inc. (ANTX) have in its pipeline
ANTX is currently developing the following drugs: An2-502998, Epetraborole. These drug candidates are in various stages of clinical development as the company works toward FDA approval.